Effect of the Administration of the Combination of Dapagliflozin Plus Metformin XR Versus Monotherapies on Anthropometric Indicators in Patients With Grade 1 Obesity
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2019
Price : $35 *
At a glance
- Drugs Dapagliflozin (Primary) ; Dapagliflozin/metformin (Primary) ; Metformin (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 05 Jul 2019 Planned End Date changed from 30 Jun 2019 to 30 Nov 2019.
- 05 Jul 2019 Planned primary completion date changed from 30 Mar 2019 to 30 Nov 2019.
- 26 Oct 2018 New trial record